Login to Your Account

Other News To Note

Monday, November 18, 2013
• Cadence Pharmaceuticals Inc., of San Diego, said the U.S. District Court for the District of Delaware has ruled in favor of Cadence in the company’s patent infringement lawsuit against Exela Pharma Sciences LLC, of Lenoir, N.C., regarding Ofirmev (intravenous acetaminophen).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription